Register entryShortage reported
- Registered sites
- 8
- Active NDC listings
- 302
- Labeller names
- 10
- Live patents
- 0
- Shortage listings
- 7
- Countries
- 2
- Base
- India
Authorisation
Registered operations
Analytical testing7Active ingredient (API) manufacture4Labelling8Finished drug manufacture4Packaging8Relabelling1Repackaging1
Sites
Registered establishments
8| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Granules India LimitedRegistrant: Granules India Ltd | Unit-IV, Plot No. 8, Jawaharlal Nehru Pharma City Tadi Village, Parawada Mandal, Anakapalli, Andhra Pradesh 531019, India (IND) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3006583291650376275 |
| Granules India LimitedRegistrant: Granules India Ltd | Unit-V, Plot No. 30, Jawaharlal Nehru Pharma City Parawada (M), Anakapalli, Andhra Pradesh 531019, India (IND) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3012884557860316511 |
| Granules India LimitedRegistrant: Granules India Ltd | Plot No.15 A/1, Phase-III, IDA, Jeedimetla, Quthbullapur Mandal, Medchal-Malkajgiri District, Telangana 500055, India (IND) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3001319869918457644 |
| Granules India LimitedRegistrant: Granules India Ltd | Sy.No. 160/A, 161/E, 162, 174/A, Gagillapur Village, Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Telangana 500043, India (IND) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3004097901918609236 |
| Granules India LimitedRegistrant: Granules India Ltd | H.No.6-5 & 6-11, Temple Road, Bonthapally Village, Gummadidala Mandal, Sangareddy, Telangana 502313, India (IND) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3003723146918610754 |
| GRANULES LIFE SCIENCES PRIVATE LIMITEDRegistrant: Granules India Ltd | Survey No. No. 325, 326, 333 To 336, 340 To 346 Lalgadimalakpet, Shameerpet Medchal-Malkajgiri, Telangana 500101, India (IND) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3030495702644776835 |
| Granules Pharmaceuticals Inc. | 3701 & 3725 Concorde Parkway, Chantilly, Virginia (VA) 20151, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3011585184079825711 |
| Granules Consumer Health LLC | 7413 Cushing RD, Manassas, Virginia (VA) 20109, United States (USA) | Labelling, Packaging, Relabelling, Repackaging | 3024359799118556508 |
Alert
Drug shortage listings
7| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01) | Current | Unavailable | 12 Oct 202218 Sept 2026 |
Catalogue
Drug listings by form and route
302302 active NDC listings: 152 human prescription drug, 55 human otc drug, 53 drug for further processing, 42 bulk ingredient. By marketing category: ANDA 200, DRUG FOR FURTHER PROCESSING 45, BULK INGREDIENT 35, EXPORT ONLY 15, OTC MONOGRAPH DRUG 7.
| Dosage form | NDCs |
|---|---|
| tablet | 83 |
| powder | 75 |
| tablet, extended release | 32 |
| capsule, extended release | 27 |
| capsule | 24 |
| tablet, film coated | 24 |
| tablet, film coated, extended release | 8 |
| tablet, coated | 7 |
| tablet, chewable | 6 |
| solution | 5 |
| granule | 3 |
| capsule, delayed release | 2 |
| for solution | 2 |
| tablet, delayed release | 2 |
| capsule, gelatin coated | 1 |
| Route | NDCs |
|---|---|
| oral | 205 |
| topical | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| granules pharmaceuticals inc. | 132 |
| granules india limited | 89 |
| granules india ltd | 57 |
| granules pharmaceuticals inc | 7 |
| granules usa, inc. | 7 |
| granules usa, inc. | 4 |
| granules pharmaceuticals inc. | 2 |
| granules usa, inc | 2 |
| granules pharmaceutical inc. | 1 |
| granules usa inc | 1 |
Catalogue
Marketed products
302Showing 150 of 302.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ACETAMINOPHEN | ACETAMINOPHEN | tablet, extended release, oral | 62207-183ANDA |
| ACETAMINOPHEN | ACETAMINOPHEN | tablet, extended release, oral | 62207-188ANDA |
| ACETAMINOPHEN | ACETAMINOPHEN | tablet, extended release, oral | 62207-892ANDA |
| ACETAMINOPHEN | ACETAMINOPHEN | tablet, extended release, oral | 70010-160ANDA |
| ACETAMINOPHEN | ACETAMINOPHEN | tablet, oral | 70010-161OTC MONOGRAPH DRUG |
| Aacetaminophen and Ibuprofen | Acetaminophen and Ibuprofen | tablet, oral | 69848-588ANDA |
| - | Acetaminophen | tablet | 62207-044EXPORT ONLY |
| - | Acetaminophen | tablet | 62207-078EXPORT ONLY |
| - | Acetaminophen | capsule, gelatin coated | 62207-167DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen | powder | 62207-933EXPORT ONLY |
| Acetaminophen | Acetaminophen | tablet, oral | 69848-003OTC MONOGRAPH DRUG |
| Acetaminophen | Acetaminophen | tablet, oral | 69848-008OTC MONOGRAPH DRUG |
| Acetaminophen | Acetaminophen | tablet, film coated, extended release, oral | 69848-015ANDA |
| - | Acetaminophen 80% and Diphenhydramine Hcl 4% Directly compressible granules | powder | 62207-600DRUG FOR FURTHER PROCESSING |
| Acetaminophen Diphenhydramine HCl | Acetaminophen Diphenhydramine HCl | tablet, oral | 69848-014OTC MONOGRAPH DRUG |
| - | Acetaminophen Directly compressible granules 90% | powder | 62207-100DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen Directly compressible granules 90% | powder | 62207-202DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen Directly compressible granules 90% | powder | 62207-204DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen Extra Strength | tablet | 62207-050EXPORT ONLY |
| - | Acetaminophen and Diphenhydramine Hydrochloride | tablet | 62207-661DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Diphenhydramine Hydrochloride | capsule | 62207-664DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen and Ibuprofen | tablet | 62207-588DRUG FOR FURTHER PROCESSING |
| Acetaminophen and Ibuprofen | Acetaminophen and Ibuprofen | tablet, oral | 70010-131ANDA |
| Acetaminophen and Ibuprofen Back Pain | Acetaminophen and Ibuprofen | tablet, oral | 70010-213ANDA |
| Acetaminophen, Aspirin and Caffeine | Acetaminophen, Aspirin and Caffeine | tablet, oral | 62207-680ANDA |
| Amphetamine Sulfate | Amphetamine Sulfate | tablet, oral | 70010-040ANDA |
| Amphetamine Sulfate | Amphetamine Sulfate | tablet, oral | 70010-041ANDA |
| - | Atazanavir Sulfate | powder | 62207-005DRUG FOR FURTHER PROCESSING |
| - | Avatrombopag Maleate | powder | 62207-025DRUG FOR FURTHER PROCESSING |
| - | BORTEZOMIB | powder | 62207-972BULK INGREDIENT |
| - | BUPROPION | powder | 62207-976BULK INGREDIENT |
| BUPROPION HYDROCHLORIDE | bupropion hydrochloride | tablet, film coated, extended release, oral | 70010-125ANDA |
| BUPROPION HYDROCHLORIDE | bupropion hydrochloride | tablet, film coated, extended release, oral | 70010-126ANDA |
| BUPROPION HYDROCHLORIDE | bupropion hydrochloride | tablet, film coated, extended release, oral | 70010-127ANDA |
| - | Brinzolamide | powder | 62207-011EXPORT ONLY |
| Bupropion hydrochloride | Bupropion hydrochloride | tablet, extended release, oral | 70010-784ANDA |
| Bupropion hydrochloride | Bupropion hydrochloride | tablet, extended release, oral | 70010-785ANDA |
| Butalbital, Acetaminophen and Caffeine | Butalbital, Acetaminophen and Caffeine | capsule, oral | 70010-044ANDA |
| Butalbital, Acetaminophen and Caffeine | Butalbital, Acetaminophen and Caffeine | tablet, oral | 70010-149ANDA |
| - | COMPRESSO IBU 85 PAR | powder | 62207-303DRUG FOR FURTHER PROCESSING |
| - | Calcium Oxybate | powder | 62207-994DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | powder | 62207-001DRUG FOR FURTHER PROCESSING |
| Cetirizine Hydrochloride | Cetirizine Hydrochloride | tablet, oral | 69848-006ANDA |
| Cetirizine hydrochloride | Cetirizine hydrochloride | tablet, coated, oral | 62207-764ANDA |
| Cetirizine hydrochloride | Cetirizine hydrochloride | tablet, coated, oral | 70010-163ANDA |
| Cetirizine hydrochloride - HIVES | Cetirizine hydrochloride | tablet, coated, oral | 70010-293ANDA |
| Clotrimazole | Clotrimazole | solution, topical | 69848-001OTC MONOGRAPH DRUG |
| Clotrimazole | Clotrimazole | solution, topical | 70010-229OTC MONOGRAPH DRUG |
| Colchicine | Colchicine | capsule, oral | 70010-001ANDA |
| Colchicine | Colchicine | tablet, film coated, oral | 70010-002ANDA |
| - | Compresso MF 95P | powder | 62207-400DRUG FOR FURTHER PROCESSING |
| - | Compresso MF 95P | powder | 62207-711EXPORT ONLY |
| - | Compresso PAP 90 CPC | powder | 62207-200DRUG FOR FURTHER PROCESSING |
| - | Compresso PAP 90 CPF | powder | 62207-101DRUG FOR FURTHER PROCESSING |
| - | Compresso PAP 90CPF | powder | 62207-702DRUG FOR FURTHER PROCESSING |
| - | DASATINIB | powder | 62207-973BULK INGREDIENT |
| - | DASATINIB Monohydrate | powder | 62207-986BULK INGREDIENT |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-004ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-005ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-006ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-007ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-008ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-009ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-010ANDA |
| DEXMETHYLPHENIDATE HYDROCHLORIDE | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release, oral | 70010-011ANDA |
| - | Dapagliflozin | powder | 62207-021DRUG FOR FURTHER PROCESSING |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-111ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-112ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-113ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-114ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-115ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-116ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 70010-117ANDA |
| - | Di-tert-butyl ((S)-6-oxo-6-(((S)-1-phenylpropan-2-yl) amino) hexane-1,5-diyl) dicarbamate | powder | 62207-024BULK INGREDIENT |
| - | Dimethyl Fumarate | powder | 62207-003BULK INGREDIENT |
| Dofetilide 0.125mg | Dofetilide 0.125mg | capsule, oral | 70010-024ANDA |
| Dofetilide 0.25mg | Dofetilide 0.25mg | capsule, oral | 70010-025ANDA |
| Dofetilide 0.5mg | Dofetilide 0.5mg | capsule, oral | 70010-026ANDA |
| - | Elacestrant Dihydrochloride | powder | 62207-997BULK INGREDIENT |
| - | Eltrombopag Olamine | powder | 62207-988BULK INGREDIENT |
| - | Empagliflozin | powder | 62207-026BULK INGREDIENT |
| - | Esomeprazole Magnesium Trihydrate | powder | 62207-979DRUG FOR FURTHER PROCESSING |
| Esomeprazole magnesium | Esomeprazole magnesium | capsule, delayed release, oral | 70010-133ANDA |
| Esomeprazole magnesium | Esomeprazole magnesium | capsule, delayed release, oral | 70010-134ANDA |
| Fexofenadine HCL | Fexofenadine HCL | tablet, oral | 70010-183ANDA |
| - | Fexofenadine Hydrochloride | powder | 62207-002BULK INGREDIENT |
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, oral | 62207-623ANDA |
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, oral | 62207-765ANDA |
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, oral | 62207-766ANDA |
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, film coated, oral | 62207-889ANDA |
| Fexofenadine Hydrochloride | Fexofenadine Hydrochloride | tablet, film coated, oral | 62207-891ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-108ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-109ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-118ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-926ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-927ANDA |
| GABAPENTIN | GABAPENTIN | capsule, oral | 70010-928ANDA |
| GUAIFENESIN | GUAIFENESIN | tablet, extended release, oral | 62207-569ANDA |
| GUAIFENESIN | GUAIFENESIN | tablet, extended release, oral | 62207-570ANDA |
| GUAIFENESIN | GUAIFENESIN | tablet, extended release, oral | 62207-839ANDA |
| GUAIFENESIN | GUAIFENESIN | tablet, extended release, oral | 62207-840ANDA |
| GUAIFENESIN | GUAIFENESIN | tablet, extended release, oral | 70010-199ANDA |
| - | Gabapentin | powder | 62207-996BULK INGREDIENT |
| Gabapentin | Gabapentin | tablet, film coated, oral | 70010-227ANDA |
| Gabapentin | Gabapentin | tablet, film coated, oral | 70010-228ANDA |
| Glycopyrrolate Oral Solution | Glycopyrrolate | solution, oral | 70010-106ANDA |
| - | Guaifenesin | powder | 62207-932EXPORT ONLY |
| - | Guaifenesin | powder | 62207-950EXPORT ONLY |
| Guaifenesin | Guaifenesin | tablet, extended release, oral | 69848-017ANDA |
| Guaifenesin | Guaifenesin | tablet, extended release, oral | 69848-018ANDA |
| - | Guaifenesin Directly compressible Granules 95% | powder | 62207-503DRUG FOR FURTHER PROCESSING |
| - | Guaifenesin Directly compressible granules 95% | powder | 62207-500DRUG FOR FURTHER PROCESSING |
| Guaifenesin and Pseudoephedrine HCl | Guaifenesin and Pseudoephedrine HCl | tablet, extended release, oral | 62207-827ANDA |
| Guaifenesin and Pseudoephedrine HCl | Guaifenesin and Pseudoephedrine HCl | tablet, extended release, oral | 62207-828ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 70010-672ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 70010-673ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 70010-674ANDA |
| IBUPROFEN | IBUPROFEN | tablet, oral | 62207-320ANDA |
| IBUPROFEN | IBUPROFEN | tablet, oral | 62207-321ANDA |
| - | Ibuprofen | tablet | 62207-365DRUG FOR FURTHER PROCESSING |
| Ibuprofen | Ibuprofen | tablet, oral | 62207-366ANDA |
| Ibuprofen | Ibuprofen | tablet, oral | 62207-395ANDA |
| Ibuprofen | Ibuprofen | tablet, oral | 62207-396ANDA |
| Ibuprofen | Ibuprofen | tablet, oral | 69848-011ANDA |
| Ibuprofen | Ibuprofen | tablet, oral | 69848-012ANDA |
| Ibuprofen | Ibuprofen | tablet, film coated, oral | 70010-066ANDA |
| Ibuprofen | Ibuprofen | tablet, film coated, oral | 70010-067ANDA |
| Ibuprofen | Ibuprofen | tablet, film coated, oral | 70010-068ANDA |
| - | Ibuprofen Directly compressible granules 66% | powder | 62207-300DRUG FOR FURTHER PROCESSING |
| - | Ibuprofen Directly compressible granules 66% | powder | 62207-311DRUG FOR FURTHER PROCESSING |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-206ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-207ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-208ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-209ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-210ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-211ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 70010-212ANDA |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 70010-187ANDA |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 70010-188ANDA |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | tablet, film coated, oral | 70010-189ANDA |
| - | Lapatinib Ditosylate | powder | 62207-980BULK INGREDIENT |
| - | Levetiracetam | powder | 62207-985DRUG FOR FURTHER PROCESSING |
| Levetiracetam | Levetiracetam | tablet, film coated, oral | 70010-521ANDA |
| Levetiracetam | Levetiracetam | tablet, film coated, oral | 70010-522ANDA |
| Levetiracetam | Levetiracetam | tablet, film coated, oral | 70010-523ANDA |
| Levetiracetam | Levetiracetam | tablet, film coated, oral | 70010-524ANDA |
| - | Levocetirizine dihydrochloride | powder | 62207-009BULK INGREDIENT |
| - | Linagliptin | powder | 62207-987BULK INGREDIENT |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate | tablet, chewable, oral | 70010-214ANDA |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate | tablet, chewable, oral | 70010-215ANDA |
Neighbours
Registered in the same town
12- Apitoria Pharma Private LimitedAnakapalli, IND; Sangareddy, IND · 6 sites
- LAURUS LABS LIMITEDAnakapalli, IND · 4 sites
- Dr. Reddy's Laboratories LimitedSangareddy, IND · 3 sites
- Biocon Biologics LimitedAnakapalli, IND; Sangareddy, IND · 3 sites
- Viyash Scientific LimitedAnakapalli, IND; Sangareddy, IND · 3 sites
- Arene Life Sciences Private LimitedSangareddy, IND · 3 sites
- Aurobindo Pharma LimitedSangareddy, IND · 2 sites
- EUGIA Pharma Specialities LimitedAnakapalli, IND; Sangareddy, IND · 2 sites
- Honour Lab LimitedSangareddy, IND · 2 sites
- Lee Pharma LimitedAnakapalli, IND; Sangareddy, IND · 2 sites
- Metrochem API Private LimitedSangareddy, IND · 2 sites
- LAURUS SYNTHESIS PRIVATE LIMITEDAnakapalli, IND · 2 sites
Compare
Comparable companies in India
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Indoco Remedies Limited7 sites · 58 NDC
- Viyash Scientific Limited9 sites · 58 NDC
Enquiry
Common questions
- Is Granules Pharmaceuticals Inc. FDA approved?
- Granules Pharmaceuticals Inc. holds 8 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Granules Pharmaceuticals Inc.'s drugs manufactured?
- At registered sites in India, the United States. The FDA register lists Anakapalli; Medchal-Malkajgiri District; Sangareddy; Shameerpet Medchal-Malkajgiri; Chantilly, VA; Manassas, VA. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging.
- What drugs does Granules Pharmaceuticals Inc. make?
- 302 products are listed under Granules Pharmaceuticals Inc. in the openFDA NDC Directory, most often as tablet; powder; tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Granules Pharmaceuticals Inc. products in shortage?
- 7 presentations are currently listed in the FDA drug shortage database under Granules Pharmaceuticals Inc., covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.